Literature DB >> 6999353

Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin.

R A DeFronzo, R Lang.   

Abstract

Although hypophosphatemia is commonly present in diabetics, little is known about its isolated effects on glucose and insulin metabolism. We therefore investigated glucose metabolism in six nondiabetic subjects with chronic hypophosphatemia. When glucose was infused to maintain a constant hyperglycemic level (125 mg per deciliter [6.9 mmol per liter] above basal levels), the glucose infusion rate was 36 per cent less in the hypophosphatemic group than in controls (4.90 +/- 0.34 mg per kilogram of body weight per minute vs. 7.64 +/- 0.37, P < 0.001), although responses to endogenous insulin were similar. When exogenous insulin was infused at a constant rate to maintain an insulin level about 100 microU per milliliter (718 pmol per liter) above basal levels and glucose was infused as necessary to maintain fasting glucose levels, the infusion rate of glucose was 43 per cent lower in the hypophosphatemic group than in controls (3.80 +/- 0.58 mg per kilogram per minute vs. 6.70 +/- 0.33, P < 0.001), although the clearance rate of insulin was similar in both groups. These results indicate that hypophosphatemia is associated with impaired glucose metabolism in both the hyperglycemic and euglycemic states, and that this associated primarily reflects decreased tissue sensitivity to insulin. (N Engl J Med. 1980; 303; 1259-63.).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999353     DOI: 10.1056/NEJM198011273032203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  36 in total

Review 1.  The role of Klotho in energy metabolism.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

Review 2.  Working group reports: evaluation of the evidence to support practice guidelines for nutritional care of preterm infants-the Pre-B Project.

Authors:  Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton
Journal:  Am J Clin Nutr       Date:  2016-01-20       Impact factor: 7.045

3.  Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery.

Authors:  R Prager; G Schernthaner; B Niederle; R Roka
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

4.  Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study.

Authors:  Carlos Lorenzo; Anthony J Hanley; Marian J Rewers; Steven M Haffner
Journal:  Diabetologia       Date:  2014-04-26       Impact factor: 10.122

5.  Recurrent diabetic ketoacidosis: a rare presenting manifestation of primary hyperparathyroidism.

Authors:  Rajesh Rajput; Ashima Mittal; Jasminder Singh; Satish Dalal; Shaweta Vohra
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

6.  Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance.

Authors:  R Prager; G Schernthaner; J Kovarik; G Cichini; K Klaushofer; R Willvonseder
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

7.  Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia.

Authors:  Thierry Charron; Francis Bernard; Yoanna Skrobik; Nathalie Simoneau; Nadine Gagnon; Martine Leblanc
Journal:  Intensive Care Med       Date:  2003-07-05       Impact factor: 17.440

8.  Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis.

Authors:  Jørn Ditzel; Hans-Henrik Lervang
Journal:  Vasc Health Risk Manag       Date:  2010-10-05

Review 9.  Derangement of glucose metabolism in hyperparathyroidism.

Authors:  M Procopio; G Borretta
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

10.  A clinical approach to common electrolyte problems: 3. Hypophosphatemia.

Authors:  C Berkelhammer; R A Bear
Journal:  Can Med Assoc J       Date:  1984-01-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.